Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Carlos J. Gimeno is active.

Publication


Featured researches published by Carlos J. Gimeno.


Diabetes | 1997

Cloning and Characterization of an Uncoupling Protein Homolog: A Potential Molecular Mediator of Human Thermogenesis

Ruth E. Gimeno; Marlene Dembski; Xun Weng; Nanhua Deng; Andrew W. Shyjan; Carlos J. Gimeno; Francois Iris; Stephen J Ellis; Elizabeth A. Woolf; Louis A. Tartaglia

We have identified a novel cDNA encoding a protein highly homologous to the mammalian brown fat uncoupling protein (UCP). Unlike the known UCP, which is expressed specifically in brown adipose tissue, the UCP homolog (UCPH) mRNA is expressed in a variety of tissues, with predominant expression in human white adipose tissue and skeletal muscle. In the white adipose tissue of ob/ob and db/db mice, the UCPH transcript is induced approximately fivefold relative to lean littermate controls. Expression of murine UCPH in yeast results in growth inhibition under conditions that require aerobic respiration, but does not affect growth under anaerobic conditions. Furthermore, UCPH expression in yeast causes a decrease in the mitochondrial membrane potential, as judged by staining with the potential-sensitive dye DiOC6. These observations suggest that UCPH, like UCP, uncouples oxidative phosphorylation. The possibility that the UCPH protein is an important mediator of human thermogenesis is discussed.


Methods in Enzymology | 1990

[54] In vivo oxidative DNA damage : measurement of 8-hydroxy-2'-deoxyguanosine in DNA and urine by high-performance liquid chromatography with electrochemical detection

Mark K. Shigenaga; Jeen-Woo Park; Kenneth C. Cundy; Carlos J. Gimeno; Bruce N. Ames

Abstract HPLC with electrochemical detection is a highly sensitive and selective method for detecting the oxidatively modified DNA residue oh 8 dG. By this method, the detection of oh 8 dG from DNA and urine offers a powerful approach for assessing in vivo oxidative damage. Application of this technique to the detection of oh 8 dG from DNA permits the quantitation of the steady-state levels of this oxidatively modified deoxynucleoside and overcomes the detection problems associated with the extremely low levels present in DNA. In addition, the selectivity gained by this detection method eliminates the problem of separating the signal for oh 8 dG from normal deoxynucleosides. The quantitation of oh gdG in urine complements the measurement of oh 8 dG in DNA by estimating cumulative oxidative DNA damage in the body. In addition, the urinary assay provides a noninvasive means of measuring this type of damage in laboratory animals and human populations. Thus, an individual animal or human subject may be monitored over time, possibly under various prooxidant conditions, using oh 8 dG as a sensitive marker for oxidative DNA damage. This analytical approach may allow one to estimate the exposure of an individual to prooxidant conditions associated with lifestule, genetic predisposition, degenerative diseases, and environmental toxins.


Proceedings of the National Academy of Sciences of the United States of America | 1989

Urinary 8-hydroxy-2'-deoxyguanosine as a biological marker of in vivo oxidative DNA damage

Mark K. Shigenaga; Carlos J. Gimeno; Bruce N. Ames


Proceedings of the National Academy of Sciences of the United States of America | 1997

Vascular MADs: Two novel MAD-related genes selectively inducible by flow in human vascular endothelium

James N. Topper; Jiexing Cai; Yubin Qiu; Keith R. Anderson; Yong-Yao Xu; James D. Deeds; Roslyn Feeley; Carlos J. Gimeno; Elizabeth A. Woolf; Olga Tayber; Gail G. Mays; Barbara A. Sampson; Frederick J. Schoen; Michael A. Gimbrone; Dean Falb


Archive | 1996

RP compositions and therapeutic and diagnostic uses therefor

Carlos J. Gimeno; Patrick W. Kleyn; Karen J. Moore


Archive | 1997

Genes encoding proteins that interact with the tub protein

Carlos J. Gimeno; Patrick R. Errada


Archive | 1997

Weight control pathway genes and uses therefor

Carlos J. Gimeno; Patrick R. Errada


Archive | 1996

Conservin nucleic acid molecules and compositions

Dean Falb; Carlos J. Gimeno


Archive | 1999

Assay for agents which alter G-protein coupled receptor activity

Kevin T. Madden; Patrick R. Errada; Carlos J. Gimeno


Archive | 1997

Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders

Douglas Adam Levinson; Carlos J. Gimeno

Collaboration


Dive into the Carlos J. Gimeno's collaboration.

Top Co-Authors

Avatar

Patrick R. Errada

Millennium Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Dean Falb

Millennium Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Bruce N. Ames

Children's Hospital Oakland Research Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mark K. Shigenaga

Children's Hospital Oakland Research Institute

View shared research outputs
Top Co-Authors

Avatar

Susan Acton

Millennium Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Andrew W. Shyjan

Millennium Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Barbara A. Sampson

Albert Einstein College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Francois Iris

Millennium Pharmaceuticals

View shared research outputs
Researchain Logo
Decentralizing Knowledge